Stockscreener 앱 받기
50.65
0.10%
-0.14
Akero Therapeutics Inc 주식(AKRO)의 최신 뉴스
Kennondale Capital Management LLC Cuts Position in Akero Therapeutics, Inc. (NASDAQ:AKRO) - MarketBeat
What analysts say about Akero Therapeutics Inc. stockFree Stock Market Knowledge Sharing - PrintWeekIndia
Jennison Associates LLC Invests $533,000 in Akero Therapeutics, Inc. (NASDAQ:AKRO) - MarketBeat
Is Akero Therapeutics Inc. stock a growth or value playFree Trend-Following Techniques - jammulinksnews.com
How to Take Advantage of moves in (AKRO) - news.stocktradersdaily.com
What drives Akero Therapeutics Inc. stock pricePhenomenal wealth increase - Autocar Professional
Readystate Asset Management LP Invests $4.07 Million in Akero Therapeutics, Inc. (NASDAQ:AKRO) - MarketBeat
Akero Therapeutics Inc. Stock Analysis and ForecastFastest-growing stock picks - Autocar Professional
Is Akero Therapeutics Inc. a good long term investmentHigh-velocity gains - Autocar Professional
6,947 Shares in Akero Therapeutics, Inc. (NASDAQ:AKRO) Acquired by Edgestream Partners L.P. - MarketBeat
Akero Therapeutics, Inc. (NASDAQ:AKRO) Insider Sells $529,500.00 in Stock - MarketBeat
Bank of New York Mellon Corp Purchases 12,235 Shares of Akero Therapeutics, Inc. (NASDAQ:AKRO) - MarketBeat
Xponance Inc. Buys Shares of 5,565 Akero Therapeutics, Inc. (NASDAQ:AKRO) - MarketBeat
257,025 Shares in Akero Therapeutics, Inc. (NASDAQ:AKRO) Purchased by Principal Financial Group Inc. - MarketBeat
Mirum Gains 35% in 3 Months: How Should You Play the Stock? - The Globe and Mail
Akero Therapeutics, Inc. (NASDAQ:AKRO) Receives $82.50 Average Price Target from Analysts - MarketBeat
Emerald Advisers LLC Has $11.92 Million Stock Holdings in Akero Therapeutics, Inc. (NASDAQ:AKRO) - MarketBeat
How Akero Therapeutics Inc. stock performs during market volatilityFree Stock Market Forecasting Tools - beatles.ru
Emerald Mutual Fund Advisers Trust Sells 145,145 Shares of Akero Therapeutics, Inc. (NASDAQ:AKRO) - MarketBeat
Akero Therapeutics, Inc. (NASDAQ:AKRO) CEO Andrew Cheng Sells 30,000 Shares - MarketBeat
Learn to Evaluate (AKRO) using the Charts - news.stocktradersdaily.com
Akero Therapeutics, Inc. (NASDAQ:AKRO) Insider Sells $638,625.00 in Stock - MarketBeat
Akero Therapeutics CEO Cheng sells $1.5m in stock By Investing.com - Investing.com Canada
Akero Therapeutics CEO Cheng Andrew sells 14686 shares at $50.57/share on July 10. - AInvest
Akero Therapeutics, Inc. (NASDAQ:AKRO) VP Patrick Lamy Sells 2,000 Shares - MarketBeat
(AKRO) Investment Report - news.stocktradersdaily.com
Oppenheimer & Co. Inc. Invests $297,000 in Akero Therapeutics, Inc. (NASDAQ:AKRO) - MarketBeat
Akero Therapeutics, Inc.(NasdaqGS: AKRO) dropped from Russell 3000 Value Index - MarketScreener
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Akero Therapeutics, Inc. (AKRO) and Encourages Stockholders to Learn More About the Investigation - ACCESS Newswire
Akero Therapeutics, Inc. (NASDAQ:AKRO) CTO Scott A. Gangloff Sells 848 Shares - MarketBeat
Akero Therapeutics, Inc. (NASDAQ:AKRO) Receives $82.50 Consensus Price Target from Analysts - MarketBeat
1.74%
0.00%
자본화:
|
볼륨(24시간):